Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3829-3837

  He, Hong ^a   Watanabe, Takeshi ^b   Zhan, Xi ^c   Huang, Cai ^c   Schuuring, Ed ^d   Fukami, Kiyoko ^e   Takenawa, Tadaomi ^e   Kumar, C Chandra ^f   Simpson, Richard J ^a   Maruta, Hiroshi ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b KYUSHU UNIVERSITY   (Japan)

^c HOLLAND LABORATORY   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UNIVERSITY OF TOKYO   (Japan)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONFORMATIONAL TRANSITION; ENZYME SUBSTRATE COMPLEX; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ANIMALIA;

EID: 17344380140     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3829     Document Type: Article

References (55)

1. Bar-Sagi, D., and J. Feramisco. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by Ras proteins. Science 233:1061-1065.
2. Bleasby, A. J., and J. C. Wotton. 1990. Construction of validated, non-redundant composite protein sequences in a protein database. Protein Eng. 3:153-159.
3. Choi, O. H., C. S. Park, K. Itoh, R. S. Adelstein, and M. Beaven. 1996. Cloning of cDNA encoding rat myosin II-A heavy chain and evidence for the absence of myosin II-B heavy chain in cultured rat mast (RBL-2H#) cells. J. Muscle Res. Cell Motil. 17:69-77.
4. D'Abaco, G., R. Whitehead, and A. W. Burgess. 1996. Synergy between APC (Min) and an activated Ras mutation is sufficient to induce colon carcinomas. Mol. Cell. Biol. 16:884-891.
5. Eng, J. K., A. McCormack, and J. Yates. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. Am. Soc. Mass Spectrom. 5:976-989.
6. Fernandez, J. L. R., B. Geiger, D. Salomon, I. Sabanay, M. Zoeller, and A. Ben-Ze'ev. 1992. Suppression of tumorigenicity in SV40-transformed cells after transfection with vinculin cDNA. J. Cell Biol. 119:427-438.
7. 2 inhibits oncogene induced mitogenesis. Proc. Natl. Acad. Sci. USA 85:9057-9061.
8. 2 for alpha-actinin function. Nature 359: 150-152.
9. 2-binding proteins involved in signaling by Tyr kinase. J. Biol. Chem. 269:1518-1522.
10. Fukui, Y., T. Lynch, H. Brzeska, and E. D. Korn. 1989. Myosin I is located at the leading edges of locomoting Dictyostelium amoeba. Nature 341:328-331.
11. Gibbs, J. B., R. Elis, and E. M. Scolnick. 1984. Autophosphorylation of v-Ha-Ras is modulated by amino acid 12. Proc. Natl. Acad. Sci. USA 81: 2674-2678.
12. Gimona, M., J. Kazzaz, and D. Helfman. 1996. Forced expression of tropo -myosin2 and 3 in v-Ki-Ras-transformed fibroblasts results in distinct phenotypic effects. Proc. Natl. Acad. Sci. USA 93:9618-9623.
13. Glueck, U., D. Kwiatkowski, and A. Ben-Ze'ev. 1993. Suppression of tumor-igenicity in SV40-transformed 3T3 cellls transfected with alpha-actinin cDNA. Proc. Natl. Acad. Sci. USA 90:383-387.
14. Hartwig, J., G. M. Bokoch, C. L. Carpenter, P. Janmey, L. Taylor, A. Toker, and T. Stossel. 1995. Thrombin receptor ligation and activate Rac uncap actin filament barbed ends through phosphoinositide synthesis. Cell 82:643-653.
15. He, H. 1997. HS1 and EMS1. Jpn. J. Cancer Chemother. 24:1448-1453.
16. 2 turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:37-51.
17. Huang, C., Y. Ni, T. Wang, Y. Gao, C. C. Haudenschild, and X. Zhan. 1997. Down-regulation of F-actin cross-linking activity of cortactin/EMS1 by Src-mediated Tyr phosphorylation. J. Biol. Chem. 272:13911-13915.
18. 2. Nature 325:362-364.
19. Janssen, R., and J. Mier. 1997. Tropomyosin-2 cDNA lacking the 3′ untranslated region riboregulator induces growth inhibition of v-Ki-Ras-transformed fibroblasts. Mol. Biol. Cell 8:897-908.
20. Kitamura, D., H. Kaneko, Y. Miyazgoe, T. Ariyasu, and T. Watanabe. 1989. Isolation and characterization of a novel human gene expressed specially in the cells of hematopoietic lineage. Nucleic Acids Res. 17:9367-9379.
21. Kumar, C. C., C. Prorock-Rogers, J. Kelley, Z. Dong, J. J. Lin, L. Armstrong, H. F. Kung, M. J. Weber, and A. Afonso. 1995. SCH51344 inhibits Ras transformation by a novel mechanism. Cancer Res. 55:5106-5117.
22. Lassing, I., and U. Lindberg. 1988. Evidence that the phosphatidylinositol cycle is linked to cell motility. Exp. Cell Res. 174:1-15.
23. Maruta, H., and E. D. Korn. 1977. Acanthamoeba myosin II. J. Biol. Chem. 252:6501-6509.
24. Maruta, H., J. Holden, A. Sizeland, and G. D'Abaco. 1991. The residues of Ras and Rap proteins that determine their GAP specificities. J. Biol. Chem. 266:11661-11668.
25. Maruta, H., and H. He. 1995. Cytoskeletal SH3 proteins. Biochemistry (Tokyo) 67:1210-1217.
26. Maruta, H. 1996. Downstream of RAS and actin-cytoskeleton, p. 139-180. In H. Maruta and A. W. Burgess (ed.), Regulauon of the RAS signaling network. Springer-Verlag, Heidelberg, Germany.
27. Maruta, H. 1997. F-actin cappers. Jpn. J. Cancer Chemother. 24:1442-1447.
28. Moritz, R. L., and R. J. Simpson. 1992. Application of capillary reversed-phase high-performance liquid chromatography to high-sensitive protein sequence analysis. J. Chromatogr. 599:119-130.
29. Moritz, R. L., J. Eddes, G. Reid, and R. J. Simpson. 1996. S-pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: a rapid mass spectrometric method for identifying cysteine-containing peptides. Electrophoresis 17:907-917.
30. Muellauer, L., H. Fujita, A. Shizaki, and N. Kuzumaki. 1993. Tumor-suppressive function of mutated gelsolin in Ras-transformed cells. Oncogene 8:2531-2536.
31. Nur-E-Kamal, M. S. A., A. Sizeland, G. D'Abaco, and H. Maruta. 1992. Asn26, Glu31, Val45, and Tyr64 of Ras proteins are required for their oncogenicity. J. Biol. Chem. 267:1415-1418.
32. Pollard, T. D., and J. A. Cooper. 1986. Actin and actin-binding proteins. A critical evaluation of mechanisms and function. Annu. Rev. Biochem. 55: 987-1035.
33. Prasad, G., R. Fuldner, and H. Cooper. 1993. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the Ras oncogene. Proc. Natl. Acad. Sci. USA 90:7039-7043.
34. Qiu, R. G., J. Che, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374:457-459.
35. Rodriguez-Viciana, P., P. Warne, A. Khwaja, B. Marte, D. Pappin, P. Das, M. Waterfield, A. Ridley, and J. Downward. 1997. Role of PI-3 kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
36. Saez, C. G., J. Myers, T. Shows, and L. Leinward. 1990. Human non-muscle II heavy chain mRNA: generation of diversity through alternative polyadenylylation. Proc. Natl. Acad. Sci. USA 87:1154-1168.
37. Saito, Y., and K. Umezawa. 1997. Synthesis of echiguanine analogues and their ribofuranosyl glycosides that inhibit PI-4 kinase. Bioorg. Med. Chem. Lett. 7:861-864.
38. Sato, N., S. Yonemura, T. Obinata, S. Tsukita, and S. Tsukita. 1991. Radixin, an F-actin barbed end-capping protein, is concentrated at the cleavage furrow during cytokinesis. J. Cell Biol. 113:321-330.
39. Schuuring, E., E. Verhoeven, S. Litvinov, and R. Michalides. 1993. The product of the EMS1 gene, amplified in human carcinomas, is homologous to a Src substrate and is localized in cell-substratum contact sites. Mol. Cell. Biol. 13:2891-2898.
40. Simons, M., M. Wang, O. McBride, S. Kawamoto, K. Yamakawa, D. Gdula, R. S. Adelstein, and L. Weir. 1991. Human non-muscle myosin II heavy chains are encoded by two genes located on different chromosomes. Circ. Res. 69:530-539.
41. Spudich, J. A., and S. Watt. 1971. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of tropomyosin-troponin complex with actin and proteolytic fragments of myosin. J. Biol. Chem. 246:4866-4871.
42. Takemoto, Y., M. Furuta, X. K. Li, J. Strong-Sparks, and Y. Hashimoto. 1995. LchBP/HS1, expressed in hematopoietic lineage cells, directly associates with the SH3 domain of Lck. EMBO J. 14:3403-3414.
43. Tikoo, A., V. Ramesh, J. Gusella, and H. Maruta. 1994. Anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J. Biol. Chem. 269: 23387-23390.
44. Toothaker, L. E., D. Gonalez, N. Tung, R. Lemons, M. Lebeau, M. Arnaout, L. Clayton, and T. Tenen. 1991. Cellular myosin II heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of protein, chromosomal localization, and up-regulation during myeloid differentiation. Blood 78:1826-1833.
45. 44a. van Damme, H., V. van Buuren, and E. Schuuring. Unpublished observation.
46. Vandekerckhove, J., G. Bauw, A. Vancompernolle, B. Honore, and J. Celis. 1990. Gelsolin as one of the most prominent down-regulated markers of transformed human fibroblast and epithelial cells. J. Cell Biol. 111:95-102.
47. Walsh, A. B., M. Dhanasekaran, D. Bar-Sagi, and C. C. Kumar. 1997. SCH51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway. Oncogene 15:2553-2560.
48. Wang, D. Z. M., M. S. A. Nur-E-Kamal, A. Tikoo, W. Montague, and H. Maruta. 1997. The GTPase and Rho GAP domains of p190-A, a tumor suppressor protein that binds the Ras GAP of 120 kDa, independently function as anti-Ras tumor suppressors. Cancer Res. 57:2478-2484.
49. Weber, K., E. Lazarides, R. Goldman, A. Vogel, and R. Pollack. 1974. Localization and distribution of actin fibers in normal, transformed and revertant cells. Cold Spring Harbor Symp. Quant. Biol. 39:363-369.
50. Wu, H., and T. Parsons. 1993. Cortactin, a Src substrate of 80/85 kDa, is an F-actin binding protein enriched in the cell cortex. J. Cell Biol. 120:1417-1426.
51. Yahara, I., F. Harada, S. Sekita, K. Yoshihira, and S. Natori. 1982. Correlation between effects of 24 different cytochalasins on cellular structures and events and those on actin in vitro. J. Cell Biol. 92:69-78.
52. Yamanashi, Y., M. Okada, T. Semba, T. Yamori, H. Umemori, S. Tsunasawa, K. Toyoshima, D. Kitamura, T. Watanabe, and T. Yamamoto. 1993. Identification of HS1 as a major substrate of Tyr kinase(s) upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 90:3631-3635.
53. Yamanashi, Y., T. Fukuda, H. Nishizumi, T. Ianazu, K. Higashi, D. Kitamura, T. Ishida, H. Yamamura, T. Watanabe, and T. Yamamoto. 1997. Role of Tyr phosphorylation of HS1 in B-cell antigen receptor-mediated apoptosis. J. Exp. Med. 185:1387-1392.
54. 2 binding and actin binding activities of cofilin. J. Biol. Chem. 266:17218-17221.
55. 2-binding sequence in a G-actin binding domain of gelsolin. J. Biol. Chem. 267:14616-14621.